We are devoted to revolutionizing early cancer detection—and that’s why our team includes passionate, experienced experts with diverse industry backgrounds.
The Helio Team
We are united in our mission to change early cancer detection and save lives as a driven leadership team of researchers, operators, scientists, and more.
Shu Li, PhD
Executive Chairman
Justin Chen Li, MBA, CFA
CEO
David J. Taggart, PhD, NRCC(CC)
CSO
Richard Van Etten, MD, PhD
Chief Medical Advisor
Wei Li, PhD
Chief Bioinformatics Advisor
Anupam Bedi, MBA
VP of Quality and Regulatory Affairs
Alex Brenner, MBA
Vice President of Finance
Joyce Cheung, MBA
Head of Commercialization
Aarif Nakahooda, MBA
Board Advisor
Dr. Kenneth Chahine, Ph.D., J.D.
Board Advisor
Elizabeth Pusey M.D.
Advisor
Board Directors
Christopher DeRosa, MBA
Board Member
Terry Belmont, MPH
Board Member
Shu Li, PhD
Executive Chairman
Justin Chen Li, MBA, CFA
CEO
Richard Van Etten, MD, PhD
Chief Medical Advisor
Hepatology Medical Advisors
Mindie Nguyen, MD, MAS, AGAF, FAASLD
Hepatology Advisor and Lead Principal Investigator in CLiMB
Morris Sherman, M.D., Ph.D.
President of the International Liver Cancer Association
Ghassan K. Abou-Alfa, MD, MBA
Memorial Sloan-Kettering Cancer Center
Yujin Hoshida, MD, PhD
Liver Tumor Transitional Research Program, University of Texas Southwestern Medical Center
Robert Gish, MD
The Hepatitis B Foundation
